State of Wisconsin Investment Board
AGRX

State of Wisconsin Investment Board’s Agile Therapeutics AGRX Stock Holding History

State of Wisconsin Investment Board’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-48
Closed -$275K – 2101
2020
Q4 		$275K Buy
+48
New +$283K ﹤0.01% 1894

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

State of Wisconsin Investment Board's AGRX Position: Q1 2021 in Review

State of Wisconsin Investment Board sold out of Agile Therapeutics (AGRX) in Q1 2021, closing a stake of 48 shares — an estimated $275K sold.

State of Wisconsin Investment Board first reported a position in AGRX in Q4 2020 and held it in 1 quarter. The position peaked at $275K in Q4 2020. 73 funds tracked by Wall St. Rank hold AGRX as of Q1 2021.

  • State of Wisconsin Investment Board reported no remaining Agile Therapeutics position as of Q1 2021 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 48 Agile Therapeutics shares in Q1 2021, an estimated $275K.
  • State of Wisconsin Investment Board first reported a position in Agile Therapeutics in Q4 2020 and held it in 1 quarter.
  • State of Wisconsin Investment Board's Agile Therapeutics position peaked at $275K in Q4 2020.
  • 73 funds tracked by Wall St. Rank held Agile Therapeutics as of Q1 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2021, filed 17 May 2021.